To The Moon

$Interactive Brokers(IBKR)$ $Interactive Brokers (IBKR) +4.47%: Brokerage Leader Charges Toward 52-Week High, $95 Breakout Watch Latest Close: $93.87 (+4.02, +4.47%) as of 2026-08-24, just 4.1% below the 52-week high of $97.84. Intraday range: $90.31–$94.22. Market Drivers: 🚀 Volume ratio hit 1.78x average with $538M traded — strong institutional participation. Recent Q2 beat (client assets +40% YoY) continues fueling momentum, while multiple analyst PT hikes (Piper $105, Barclays $108, Goldman $114) reinforce bullish sentiment. Technical Analysis: 📊 MACD histogram flipped decisively positive (DIF 0.25 vs DEA -0.07) — bullish crossover confirmed. RSI-6 at 64.2 (up from 44) signals renewed momentum without overbought extremes. KDJ J-value recovered

$Tesla Motors(TSLA)$ $Tesla Motors (TSLA) +5.14% Surge: Musk’s SpaceX Merger Buzz Fuels Breakout, $366 Resistance in Sight Latest Close Data: Tesla closed at $362.86 on 2026-08-24, up +5.14% (+$17.73). The stock is now ~27% below its 52-week high of $498.83, but has decisively cleared the $345–$350 consolidation zone and is approaching the $366.50 intraday high. Core Market Drivers: 🚀 Wall Street chatter around a potential Tesla–SpaceX merger intensified, with RBC’s Narayan suggesting SpaceX may offer a premium to Tesla shareholders. This catalyst, combined with broad risk-on sentiment in crypto and tech, fueled the breakout. Cybercab robotaxi expansion news added secondary momentum. Technical Analysis: 📊 Volume surged to 59.22M shares (Volume Rat

$Amgen(AMGN)$ $AMGN +1.88% Momentum Builds: Amgen Nears 52-Week High, $457 Target in Sight Latest Close: $439.33 (+1.88%) on Aug 24, 2026 · Just 0.9% below the 52-week high of $443.20. After-hours price: $441.12. Core Market Drivers: Amgen continues to ride the post-earnings momentum from its Q2 beat (EPS $6.29 vs $5.62 est.) and raised full-year guidance. The company's strategic decision to terminate early-stage obesity drug AMG 513 and focus resources on Phase III MariTide has reinforced pipeline discipline. Short volume ratio at 15.25% suggests manageable bearish pressure. Technical Analysis: MACD remains firmly bullish with DIF at 17.03 vs DEA at 14.93 (histogram +4.19), confirming strong upward momentum. RSI(6) at 74.46 and RSI(12) at 73.96 i

$Ferrari NV(RACE)$ $RACE Ferrari Surges +1.91%: Luxury Supercar Maker Tests $437 Resistance, $490 Bull Target in Sight 🏎️💨 Latest Close Data: $RACE closed at $436.54 (+1.91%) on Aug 24, just 0.22% below its short-term resistance of $437.51 and 13.5% off its 52-week high of $504.49. Core Market Drivers: Goldman Sachs lifted its Ferrari target from €381 to €407, while AlphaValue raised its target from €401 to €422. Luxury demand remains resilient despite macro noise, with Ferrari's brand pricing power shielding margins. Technical Analysis: Volume reached 444.2K shares with a 1.15 volume ratio, confirming accumulation. MACD is strongly bullish with DIF at 13.27 vs DEA 11.52, histogram expanding to +3.49. RSI(6) hit 83.5 — overbought but still rising,

$General Motors(GM)$ $GM Surges +2.07% to $87.93: Legacy Automaker Breaks Consolidation, $89.19 Resistance in Sight 🚗⚡ Latest Close Data 📊 GM closed at $87.93 on Aug 24, 2026 (+2.07%), just 4.27% below its 52-week high of $91.85. Volume hit 5.27M shares with a 1.22 volume ratio, signaling accumulation. Core Market Drivers 📰 Detroit automakers remain focused on USMCA renegotiation risks, but GM's EV transition and Jefferies' July upgrade (Hold→Buy, PT $99) continue underpinning sentiment. The stock extended gains after breaking above its prior consolidation zone. Technical Analysis 🔍 MACD remains negative at -0.84, but DIF (-0.84) is converging toward DEA (1.52), suggesting bearish momentum fading. RSI(6) jumped to 62.55 from 51.58, while RSI(12) rea

$Las Vegas Sands(LVS)$ $Las Vegas Sands(LVS) +2.31% Breakout Attempt: Casino Giant Reclaims $47, MACD Turns Bullish Latest Close: $47.03 (+2.31%) | Range $46.18–$47.08 | 52W High $70.45 | 52W Low $44.21 Core Drivers: LVS bounced off its 52-week low zone as Macau/Singapore recovery sentiment stabilized. Post-market strength (+$0.32 to $47.35) signals continued accumulation after July's post-earnings selloff, when Q2 EPS of $0.59 missed estimates and multiple banks cut targets. Technical Analysis: Volume came in at 3.29M shares (Volume Ratio 0.84), indicating moderate but not explosive participation. MACD just crossed bullish — DIF at -0.235 vs DEA -0.331, producing a positive histogram of +0.192, confirming short-term momentum shift. RSI(6) jumped t

$DexCom(DXCM)$ $DexCom, Inc.(DXCM) +2.35% Hits 52-Week High at $92.56, Breakout Above $92.43 Resistance Activates $95–$100 Target Zone 🚀 Latest Close Data DXCM closed at $92.34 (+2.35%) on Aug 24, 2026, matching its 52-week high of $92.56 intraday. Price now sits just 0.24% below that high, with after-hours action pushing to $92.50 — a decisive breakout signal above the prior $92.43 resistance shelf. Core Market Drivers Q2 earnings (Jul 31) remain the primary catalyst: EPS of $0.70 beat by $0.09 (+45.8% YoY), revenue of $13.08B exceeded consensus, and full-year guidance was raised to $51.8–$52.5B on strong continuous glucose monitor demand. Short volume has contracted sharply from 1.54M (Aug 11) to 537K (Aug 21), indicating bearish conviction fadi

$Merck(MRK)$ $Merck & Co., Inc.(MRK) +2.39% Closes at $152.55: mRNA Cancer Vaccine Breakthrough Fuels All-Time High, $154.49 Resistance in Sight 🚀 Latest Close Data: MRK closed at $152.55 (+2.39%) on Aug 24, 2026, just 1.3% below its 52-week high of $154.49. Pre-market had indicated $148.70, while after-hours extended to $154.14, suggesting continued momentum into the next session. Core Market Drivers: Merck and Moderna's personalized mRNA cancer vaccine intismeran autogene + Keytruda achieved a historic Phase III success in INTerpath-001, hitting the primary RFS endpoint — the first positive Phase III result for an individualized mRNA cancer vaccine. Morgan Stanley upgraded MRK from Equalweight to Overweight, lifting its price target from $116

$Affirm Holdings, Inc.(AFRM)$ $AFRM Affirm Holdings +2.64%: Momentum Reclaims $77, $81 Resistance Next Target Latest Close Data: AFRM closed at $77.03 (+2.64%) on Aug 24, 2026, with volume of 2.39M shares (Volume Ratio 0.83). Price sits 23% below the 52-week high of $100.00, and 83% above the 52-week low of $42.09. Core Market Drivers: Bernstein recently initiated coverage with an "Outperform" rating, and BofA raised its target from $88 to $93. Analysts cite Affirm's expanded $675M credit facility (extended to 2029) and the renewed $1.7B forward flow agreement with CPP Investments as key liquidity catalysts. 💳 Technical Analysis: MACD remains bullish with DIF (0.11) above DEA (0.01), though momentum is moderating. RSI(6) at 54.9 and RSI(12) at 52.

$Toyota(TM)$ $Toyota Motor Corp.(TM) +2.66% Closes at $197.35 — Bullish Breakout Eyes $218.96 Resistance, $220+ Target in Play 🚗⚡ Latest Close Data TM closed at $197.35 (+2.66%) on Aug 24, adding $5.11 with volume of 36.91万 (Volume Ratio 1.24, above average). Price is now 20.7% below the 52-week high of $248.90, and sits just 9.9% below the identified resistance at $218.96. Core Market Drivers Toyota extended its rebound as investors rotated into value/defensive auto names with a 3.02% dividend yield and P/E of only 9.18. Broad market focus on shareholder returns and capital efficiency supported the move; no company-specific catalyst dominated, but short-volume ratio eased from 18.88% to ~14% over the prior week, reducing near-term supply pressure.